Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

NCT02260817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Prostate Cancer

Interventions

DRUG: 11C-choline Injection

Sponsor

Global Isotopes, LLC d/b/a Zevacor Molecular